The integration of adhesion, redox, and exosome–miRNA signaling within the CDH2-centered RAX hub converges on three malignant hallmarks: maintenance of cancer stemness, metastatic competence, and immune evasion [127,128]. The gene discussed is RAX; the disease is cancer.